EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY-NC 4.0

Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea

Dong Wook Kim iD, Minkook Son iD, Hye Jung Lee, Chi Hyeon Choi, Yeo Wool Kang iD, Sang Yi Moon iD, Myeongseok Koh iD, Jong Yoon Lee iD, Yang Hyun Baek iD, Won Suk An

Hepatology Research · 2025-09 · 55 (9) · 1239-1250

DOI: 10.1111/hepr.14226 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Hepatology Research, online erschienen am 16.06.2025. Verfasst von Dong Wook Kim und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Dong-A University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

The shift in terminology from nonalcoholic fatty liver disease (NAFLD) to metabolic dysfunction‐associated steatotic liver disease (MASLD) highlights its association with metabolic dysfunction. MASLD is defined by hepatic steatosis and at least one cardiometabolic risk factor (CMRF), which contribute to chronic kidney disease (CKD). This study examines the relationship between MASLD and CKD, the independent impact of CMRFs on CKD risk, and the cumulative effect of multiple CMRFs on CKD development.

Methods

The present retrospective cohort study utilized data from the Korean National Health Insurance System (NHIS), analyzing 211,992 individuals aged ≥ 40 years who underwent health screenings between 2009 and 2010. The average observation period was 9.1 years. Participants were classified into groups: no steatotic liver disease (SLD) without CMRF, no SLD with CMRF, MASLD, and metabolic dysfunction‐associated steatotic liver disease with increased alcohol intake (MetALD).

Results

Compared to the no SLD without CMRF group, the adjusted hazard ratios (HRs) for CKD were 1.27 (95% CI: 1.18–1.37) for no SLD with CMRF, 1.70 (95% CI: 1.58–1.83) for MASLD, and 1.47 (95% CI: 1.33–1.63) for MetALD. CKD risk increased with the number of CMRFs, with adjusted HRs increasing from 1.12 (one CMRF) to 1.97 (four CMRFs).

Conclusions

MASLD is independently associated with increased CKD risk. Each CMRF independently contributes to CKD development, and the cumulative effect of multiple CMRFs further amplifies this. This suggests that MASLD is an effective predictor of CKD risk. Given the rising burden of MASLD and its complications, early identification and management of risk factors are crucial for reducing CKD incidence.

Schlagwörter

Stichwörter der Autor:innen

cardiometabolic risk factors (CMRFs)chronic kidney disease (CKD)metabolic dysfunction‐associated steatotic liver disease (MASLD)metabolic dysfunction‐associated steatotic liver disease with increased alcohol…

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea.
  • Department of Physiology, Dong-A University College of Medicine, Busan, South Korea.
  • Department of Data Sciences Convergence, Dong-A University Interdisciplinary Program, Busan, South Korea.
  • Division of Nephrology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, South Korea.

ORCID-Profile: Dong Wook Kim, Minkook Son, Yeo Wool Kang, Sang Yi Moon, Myeongseok Koh, Jong Yoon Lee, Yang Hyun Baek

Förderung

  • Dong-A University

Zitieren

APA

Kim, D. W., Son, M., Lee, H. J., Choi, C. H., Kang, Y. W., Moon, S. Y., Koh, M., Lee, J. Y., Baek, Y. H., & An, W. S. (2025). Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea. Hepatology Research, 55(9), 1239-1250. https://doi.org/10.1111/hepr.14226

Vancouver

Kim DW, Son M, Lee HJ, Choi CH, Kang YW, Moon SY, et al. Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea. Hepatology Research. 2025;55(9):1239-1250. doi:10.1111/hepr.14226

BibTeX
@article{Kim2025,
  author = {Kim, Dong Wook and Son, Minkook and Lee, Hye Jung and Choi, Chi Hyeon and Kang, Yeo Wool and Moon, Sang Yi and Koh, Myeongseok and Lee, Jong Yoon and Baek, Yang Hyun and An, Won Suk},
  title = {Chronic Kidney Disease Risk Associated With Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Nationwide Cohort Study in Korea},
  journal = {Hepatology Research},
  year = {2025},
  volume = {55},
  number = {9},
  pages = {1239--1250},
  doi = {10.1111/hepr.14226}
}
Kostenlos starten →